The recently reported KIF21A L685P substitution results in a syndromic CFEOM human phenotype that is very similar to the syndromic TUBB3-CFEOM phenotypes, with facial weakness, progressive axonal polyneuropathy, and intellectual disability in addition to CFEOM. Here, KIF21A is linked to congenital fibrosis of the extraocular muscles.